SME Times is powered by   
Search News
Just in:   • Panel formed to finalise new wage pact for TN's Tiruppur knitwear workers  • India 2nd in consumer demand of gold globally, RBI reserves rise to 880 tonnes  • Piyush Goyal to reach New Zealand tomorrow to speed up trade talks  • PM Modi inaugurates ESTIC 2025, launches Rs one lakh crore RDI Scheme Fund  • FM Sitharaman embarks on Bhutan visit to deepen economic, developmental cooperation 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» Panel formed to finalise new wage pact for TN's Tiruppur knitwear workers
» India 2nd in consumer demand of gold globally, RBI reserves rise to 880 tonnes
» Piyush Goyal to reach New Zealand tomorrow to speed up trade talks
» PM Modi inaugurates ESTIC 2025, launches Rs one lakh crore RDI Scheme Fund
» FM Sitharaman embarks on Bhutan visit to deepen economic, developmental cooperation
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter